Stocks Making the Biggest Premarket Moves: Palantir, Pepsico, Rivian and More

Check out the companies making headlines in premarket trading.

‍

Palantir Technologies:

Palantir Technologies, a data analytics powerhouse, experienced a notable uptick of 2.3% in its stock value. This surge came on the heels of a substantial announcement: the U.S. Army has bestowed upon the company a lucrative contract worth $250 million. This contract is earmarked for the testing and advancement of artificial intelligence and machine learning technologies. This development marks a pivotal moment in Palantir's journey.

‍

Unity Software:

Unity Software, a prominent player in the game engine industry, witnessed an impressive surge of nearly 6% in its stock value. The catalyst behind this surge was the announcement of CEO John Riccitiello's impending retirement. Unity Software made a strategic move by appointing James M. Whitehurst to take on the interim chief role, which resonated positively with investors.

‍

Rivian Automotive:

Rivian Automotive, a leader in electric truck manufacturing, experienced a 3% rise in its premarket stock valuation. This surge was triggered by UBS's decision to upgrade Rivian from a neutral rating to a buy. UBS expressed optimism regarding Rivian's financial prospects, citing an improvement in the company's fundamentals. Furthermore, this boost follows a successful capital raise of $1.5 billion, although it was accompanied by a brief sell-off.

‍

PepsiCo:

PepsiCo, a global beverage giant, saw its stock appreciate by approximately 1% after posting impressive third-quarter earnings results. The company reported adjusted earnings of $2.25 per share, accompanied by revenue totaling $23.45 billion. Analysts, as polled by LSEG, had projected adjusted earnings of $2.15 and revenue of $23.39 billion. PepsiCo's performance exceeded market expectations, driving investor confidence.

Ameris Bancorp:

Ameris Bancorp witnessed a modest 1% increase in its share price following DA Davidson's decision to upgrade the stock from a neutral rating to a buy. DA Davidson emphasized Ameris Bancorp's unique insulation from potential unrealized losses linked to rising interest rates, which resonated positively with investors.

‍

Arm Holdings:

The semiconductor heavyweight, Arm Holdings, recorded a commendable 2% uptick in its stock price. This increase came hot on the heels of several analysts initiating bullish coverage of the stock, including notable firms such as JPMorgan, Deutsche Bank, and Goldman Sachs. These endorsements from influential market players contributed to the stock's positive momentum.

‍

Akero Therapeutics:

Akero Therapeutics, a prominent biotech company, experienced a significant downturn, with its shares plummeting by more than 63%. This sharp decline followed the release of preliminary trial data related to a Phase 2B study concerning the cirrhosis drug efruxifermin. The market's response to this news was notably bearish, and the company faces challenges in regaining investor confidence in the wake of these developments.

‍

These premarket trading activities underscore the dynamic nature of the stock market, where companies experience fluctuations in response to a multitude of factors, including earnings reports, contract awards, leadership changes, and analyst coverage.

‍